Loading...
Indian Pharmaceutical Exporter · #6 for Regorafenib · $9.1K export value · DGFT Verified
Rmpl Pharma LLP is the #6 Indian exporter of Regorafenib with $9.1K in export value and 3 verified shipments. Rmpl Pharma LLP holds a 0.9% market share in Regorafenib exports across 3 countries. The company exports 13 pharmaceutical products worth $438.6K across 3 therapeutic categories.
| IRAQ | $18.6K | 15 | 6.3% |
| SINGAPORE | $17.6K | 9 | 6.0% |
| PHILIPPINES | $11.6K | 7 | 4.0% |
| POLAND | $8.8K | 15 | 3.0% |
| LAOS | $6.5K | 5 | 2.2% |
| TURKEY | $6.0K | 6 | 2.1% |
India exports Regorafenib to 37 countries. The top destination is THAILAND (31.7%), followed by FRANCE and KENYA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STR INTERNATIONAL TRADING CO., LTD | THAILAND | $63.2K | 3 |
| STR INTERNATIONAL TRADING CO. LIMITED | THAILAND | $12.2K | 2 |
| STR INTERNATIONAL TRADING CO., LIMITED | THAILAND | $12.2K | 2 |
| CLIENT CODE PH001, | PHILIPPINES | $7.0K | 3 |
| BZ COMPNAT LIMITED | THAILAND | $5.8K | 2 |
| SKIN LINE LOGISTIC | IRAQ | $4.6K | 7 |
| CLIENT CODE PH001 | PHILIPPINES | $4.4K | 2 |
| ZMC EXPRESS CARGO FZCO | IRAQ | $4.3K | 3 |
| VANTERPOOL ENTERPRISES LTD | BRITISH VIRGIN ISLANDS | $3.3K | 2 |
| PEKAO-CARGO SPOLKA Z O.O | POLAND | $2.8K | 2 |
India's Regorafenib is purchased by 73 buyers worldwide. The top buyer is STR INTERNATIONAL TRADING CO., LTD (THAILAND), followed by STR INTERNATIONAL TRADING CO. LIMITED and STR INTERNATIONAL TRADING CO., LIMITED.
India exported $201.3K worth of Regorafenib through 154 shipments from 60 suppliers to 37 countries, serving 73 buyers globally. Rmpl Pharma LLP contributes $9.1K to this total, accounting for 0.9% of India's Regorafenib exports.
Rmpl Pharma LLP's average Regorafenib shipment value is $3.0K per consignment, based on 3 shipments totaling $9.1K.
Rmpl Pharma LLP ranks #6 among 60 Indian Regorafenib exporters with a 0.9% market share. The top 3 exporters are KARDI TRADING PRIVATE LIMITED ($116.0K), SANSKRUTI PHARMA ($13.3K), R.S. SURGIPHARM PRIVATE LIMITED ($12.5K). Rmpl Pharma LLP processed 3 shipments to 3 destination countries.
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | 3S CORPORATION | $10.3K | 7 | 1 | $1.5K |
| 5 | LEOWIN HEALTHCARE LLP | $9.5K | 12 | 2 | $788 |
| 6 | RMPL PHARMA LLP ★ | $9.1K | 3 | 3 | $3.0K |
| 7 | P.B.P ENTERPRISES PRIVATE LIMITED | $7.9K | 3 | 1 | $2.6K |
| 8 | SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED | $5.9K | 6 | 1 | $981 |
Rmpl Pharma LLP ranks #6 among 60 Indian Regorafenib exporters. Average shipment value of $3.0K compared to the market average of $3.4K. The closest competitors by value are 3S CORPORATION and LEOWIN HEALTHCARE LLP.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 42 | 27.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 35 | 22.7% |
| DELHI AIR CARGO ACC (INDEL4) | 12 | 7.8% |
| AHEMDABAD AIR | 12 | 7.8% |
| DELHI AIR | 9 | 5.8% |
| HYDERABAD AIR | 8 | 5.2% |
| Ahmedabad Air | 6 | 3.9% |
| AHEMDABAD AIR ACC (INAMD4) | 6 | 3.9% |
Rmpl Pharma LLP also exports these advanced oncology products. Each links to the detailed product page.
Rmpl Pharma LLP exports 13 products worth $438.6K. Beyond Regorafenib, top products include Lenalidomide, Rituximab, Daratumumab, Cladribine, Ibrutinib. View the complete Rmpl Pharma LLP profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Regorafenib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 37+ countries, 73+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Rmpl Pharma LLP's Regorafenib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Rmpl Pharma LLP
Full Company Profile →
13 products · $438.6K total trade · 3 categories
Access shipment-level records, pricing trends, and buyer contacts for Rmpl Pharma LLP.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Regorafenib. For current shipment-level data, contact TransData Nexus.